Max Talbott

A Ph.D. in immunology and pharmacology, Dr. Max Talbott has served as Chief Regulatory Officer for a number of major firms and has participated in more than 500 global medical product clearances, including some of the top selling drugs on the market today. As an agent with the FDA’s Medical Device Division, Dr. Talbott was one of the key participants in the creation and implementation of the 510K, IDE and PMA regulations. As Acting Director, he managed hundreds of clinical trials and supervised numerous FDA advisory committee meetings. Dr. Talbott’s awards and recognitions include the FDA’s Commendable Service Award, membership on the Editorial Board of the Drug Information Journal, and “Who’s Who” listings in a number of professional compendia. He has authored numerous presentations and publications in the field of new drug/biologic/medical device development, health product regulatory affairs/public policy, immunology and pharmacology.